Pharmaceutical Glass Packaging Market Report (2023 to 2031) – Corning Incorporated, Bormioli Pharma SpA, Nipro Corporation, SCHOTT Group, Sisecam Group and Owens-Illinois, Inc.

Newark, New Castle, USA, May 05, 2023 (GLOBE NEWSWIRE) — According to the latest Growth Plus Reports study, the pharmaceutical glass packaging market will reach US$ 5.16 billion by 2031, with a revenue CAGR of 4.50%. The study analyzes and provides information about the market dynamics, prospects, competition, market size, data, forecasts, and key revenue growth regions.

Key Takeaways:

• The high prevalence of chronic diseases will drive market revenue growth.
• Increasing demand for high-quality glass packaging for pharmaceuticals and medicines will drive demand for pharmaceutical glass packaging.
• North America will dominate the pharmaceutical glass packaging market. 

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/pharmaceutical-glass-packaging-market/8707

                         Pharmaceutical Glass Packaging Market Scope

Market Drivers
the rapidly expanding pharmaceutical industry and the increasing demand for high-quality glass packaging for pharmaceuticals and medicines will drive the revenue growth of the pharmaceutical glass packaging market. Furthermore, the rising prevalence of chronic diseases, the rising geriatric population, and the rise in healthcare spending are expected to boost the market revenue growth rate. Apart from this, glass’s inert, non-reactive, and impermeable qualities support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global pharmaceutical glass packaging market from three perspectives: Product, Glass Type, and Region.

Product Segmentation: Based on the product, the pharmaceutical glass packaging market is segmented into bottles, vials, ampoules, cartridges and syringes, and others. The bottles segment dominates the market with the largest revenue share because bottles are a form of pharmaceutical glass packaging commonly used in the pharmaceutical industry.

Glass Type Segmentation: Based on the glass type, the pharmaceutical glass packaging market is segmented into Type I, Type II, Type III, and Type IV glass type. The Type I glass segment dominates the market because it refers to glass containers that are extremely resistant to alkalis and have little contact with their contents.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/pharmaceutical-glass-packaging-market/8707

Regional Growth Dynamics
Based on the region, the global pharmaceutical glass packaging market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the pharmaceutical glass packaging market with the largest revenue share. The launch of novel products and the presence of several key pharma companies are the major factors that are responsible for North America’s significant revenue share in the market.  

Competitive Landscape

The prominent players in the pharmaceutical glass packaging market are:

• Corning Incorporated
• Shandong Province Medicinal Glass Co., Ltd.
• Bormioli Pharma SpA
• Arab Pharmaceutical Glass Co.
• Nipro Corporation
• Gerresheimer AG
• Stoelzle Oberglas GmbH
• SCHOTT Group
• Sisecam Group
• Ardagh Group S.A
• Owens-Illinois, Inc.
• PGP Glass Private Limited

The pharmaceutical glass packaging market is competitive with several corporations. Leading companies focus on research and development and enter into mergers and acquisitions to strengthen their market position.

Recent developments:

• The state of Telangana announced a collaboration in February 2023 between SGD Pharma, a global maker of primary pharmaceutical packaging, and Corning Incorporated, a global materials science leader, to bring cutting-edge technology and manufacturing experience to the region. This collaboration will combine Corning’s high-quality pharmaceutical tubing technology with SGD Pharma’s glass vial production and conversion knowledge.
• Bormioli Pharma, a pioneer in pharmaceutical container production, announced many new research and innovation efforts in September 2022. Through the granting of a three-year Ph.D. scholarship, a partnership with IMEM-CNR is already underway inside a new Research Center devoted to glass to allow the development of new exterior and interior coatings capable of boosting glass performance, both chemically and mechanically.

Table of Content

1. INTRODUCTION    
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET- ANALYSIS & FORECAST, BY PRODUCT
   1. Bottles
   2. Vials
   3. Ampoules
   4. Cartridges and Syringes
   5. Others 
6. GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET- ANALYSIS & FORECAST, BY GLASS TYPE
   1. Type I
   2. Type II
   3. Type III
   4. Type IV

PHARMACEUTICAL GLASS PACKAGING MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8707

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Gene Amplification Technologies Market by Technology (Target Application, Loop-mediated Isothermal Amplification), Application (Medical and Pharmaceutical, and Forensic and Identity Testing) – Global Outlook & Forecast 2023-2031

Ophthalmic Knives Market by Design (Straight Knives, Crescent Knives), Product (Reusable ophthalmic Knives), Application (Cataract Surgery, Keratitis Surgery) – Global Outlook & Forecast 2023-2031

Drug Metabolizing Enzyme Market by Type (Cytochrome P450, Sulfotransferase, UDP-glucuronosyltransferase), Application (Personalized medicine, Drug Discovery & Development, Diagnostic Testing) – Global Outlook & Forecast 2023-2031

Anti-GBM Autoantibody Disease Market by Treatment Type (Immunosuppressive, Corticosteroids, Others), Distribution Channel (Hospital, Retail and Online Pharmacy) – Global Outlook & Forecast 2023-2031

Non-Hormonal Birth Control Market by Type (Contraceptive Devices, Sterilization), Gender (Male, Female) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.